Literature DB >> 5303853

Homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in serial samples of cerebrospinal fluid from the lateral ventricle of the dog.

G W Ashcroft, T B Crawford, R C Dow, H C Guldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5303853      PMCID： PMC1570237          DOI： 10.1111/j.1476-5381.1968.tb00493.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  13 in total

1.  Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine.

Authors:  A CARLSSON; N A HILLARP
Journal:  Acta Physiol Scand       Date:  1962-05

2.  On the role of monoamine oxidase for the inactivation of dopamine in brain.

Authors:  E ROSENGREN
Journal:  Acta Physiol Scand       Date:  1960-08-25

3.  The fluorimetric estimation of catechol compounds by the ethylenediamine condensation method.

Authors:  H WEIL-MALHERBE
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

4.  5-Hydroxyindoles in human cerebrospinal fluids.

Authors:  G W ASHCROFT; D F SHARMAN
Journal:  Nature       Date:  1960-06-25       Impact factor: 49.962

5.  The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain.

Authors:  D F BOGDANSKI; H WEISSBACH; S UDENFRIEND
Journal:  J Neurochem       Date:  1957       Impact factor: 5.372

6.  [Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].

Authors:  H Bernheimer; W Birkmayer; O Hornykiewicz
Journal:  Wien Klin Wochenschr       Date:  1966-06-10       Impact factor: 1.704

7.  Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid.

Authors:  H C Guldberg; C M Yates
Journal:  Br J Pharmacol Chemother       Date:  1968-07

8.  The effect of drugs on the homovanillic acid content of the corpus striatum of some rodents.

Authors:  A V Juorio; D F Sharman; T Trajkov
Journal:  Br J Pharmacol Chemother       Date:  1966-02

9.  Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

Authors:  H C Guldberg; G W Ashcroft; T B Crawford
Journal:  Life Sci       Date:  1966-09       Impact factor: 5.037

10.  A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue.

Authors:  D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more
  11 in total

1.  5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.

Authors:  B Johansson; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

2.  Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid.

Authors:  H C Guldberg; C M Yates
Journal:  Br J Pharmacol Chemother       Date:  1968-07

3.  The transport of L-tryptophan from cerebrospinal fluid in the dog.

Authors:  C Geddes; M J Martin; A T Moir
Journal:  J Physiol       Date:  1973-05       Impact factor: 5.182

4.  Idiopathic orthostatic hypotension from failure of noradrenaline release in a patient with vasomotor innervation.

Authors:  R N Nanda; F C Boyle; J S Gillespie; R H Johnson; H J Keogh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-01       Impact factor: 10.154

5.  The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog.

Authors:  G W Ashcroft; R C Dow; A T Moir
Journal:  J Physiol       Date:  1968-12       Impact factor: 5.182

6.  Effects of chlorpromazine on the metabolism of catecholamines in dog brain.

Authors:  H C Guldberg; C M Yates
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

7.  Phenolic acid concentrations in the lumbar cerebrospinal fluid of Parkinsonian patients treated with L-dopa.

Authors:  I A Pullar; J M Weddell; R Ahmed; F J Gillingham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154

8.  Influence of cerebral embolism on brain monoamines.

Authors:  N Ishihara; K M Welch; J S Meyer; E Chabi; H Naritomi; T P Wang; J H Nell; M C Hsu; A Miyakawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-09       Impact factor: 10.154

9.  Interaction in the cerebral metabolism of the biogenic amines. Effects of phenelzine on the cerebral metabolism of the 5-hydroxyindoles in dog brain.

Authors:  A T Moir
Journal:  Br J Pharmacol       Date:  1972-06       Impact factor: 8.739

10.  Interaction in the cerebral metabolism of the biogenic amines. Effect of phenelzine on this interaction.

Authors:  A T Moir; C M Yates
Journal:  Br J Pharmacol       Date:  1972-06       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.